First-Line Drug for Uncomplicated UTI
For women with uncomplicated cystitis, use nitrofurantoin 100 mg twice daily for 5 days as your first choice. 1
Treatment Algorithm for Adults
For Women with Uncomplicated Cystitis
First-line options (choose based on availability and local resistance):
- Nitrofurantoin 100 mg twice daily for 5 days 1, 2
- Fosfomycin trometamol 3 g single dose 1
- Pivmecillinam 400 mg three times daily for 3-5 days (limited availability - mainly Europe) 1
- Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days - ONLY if local E. coli resistance is <20% 1, 2
The 2024 European Association of Urology guidelines prioritize these agents because they minimize collateral damage (disruption of normal flora and promotion of resistance) while maintaining efficacy 1. Nitrofurantoin stands out with minimal resistance rates and proven efficacy comparable to trimethoprim-sulfamethoxazole 2.
Alternative options (use only when first-line agents cannot be used):
- Cephalosporins (e.g., cefadroxil 500 mg twice daily for 3 days) - only if local E. coli resistance <20% 1
- Trimethoprim alone 200 mg twice daily for 5 days 1
Reserve for other indications (NOT for simple cystitis):
- Fluoroquinolones (ciprofloxacin, levofloxacin) - highly effective but save for pyelonephritis and complicated infections due to collateral damage concerns 1, 2
For Men with Uncomplicated UTI
Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 7 days (note the longer duration) 1
Fluoroquinolones can be prescribed according to local susceptibility testing 1. Men always require 7 days of treatment, not the shorter courses used in women.
Critical Decision Points
When to Skip Antibiotics Entirely
For women with mild to moderate symptoms, consider symptomatic therapy with ibuprofen as an alternative to antibiotics after discussing with the patient 1. However, NSAIDs probably result in less symptom resolution and more rescue antibiotic use compared to primary antibiotic treatment 3.
When Urine Culture is NOT Needed
Diagnosis can be made on symptoms alone (dysuria, frequency, urgency) without vaginal discharge in women with typical presentation 1, 4. Skip the culture and treat empirically.
When Urine Culture IS Required
- Suspected pyelonephritis
- Symptoms not resolving or recurring within 4 weeks
- Atypical symptoms
- Pregnancy
- Men (always culture before treating) 1
Common Pitfalls to Avoid
Never use amoxicillin or ampicillin empirically - resistance rates are too high worldwide and efficacy is poor 2. This is a firm contraindication.
Don't use fluoroquinolones as first-line - despite their high efficacy, reserve them for pyelonephritis and complicated infections to minimize resistance development and adverse effects 1, 2.
Beta-lactams have inferior efficacy - agents like amoxicillin-clavulanate, cefdinir, and cefpodoxime should only be used when other options are unavailable, and they require 3-7 days of therapy 2.
Check local resistance patterns - the 20% resistance threshold for trimethoprim-sulfamethoxazole is critical. If your community exceeds this, don't use it empirically 2.
Treatment Failure Management
If symptoms don't resolve by end of treatment or recur within 2 weeks:
- Obtain urine culture with susceptibility testing
- Assume the organism is resistant to the original agent
- Retreat with a different agent for 7 days 1
Special Considerations
Fosfomycin has slightly inferior efficacy compared to multi-day regimens but offers the advantage of single-dose convenience and minimal resistance 2. It's particularly useful for patients with adherence concerns.
Pivmecillinam is an excellent option where available (primarily Europe) with minimal resistance, though it may have slightly lower efficacy than other first-line agents 2.
The evidence strongly supports moving away from fluoroquinolones and trimethoprim-sulfamethoxazole as automatic first choices, with nitrofurantoin emerging as the most consistently recommended first-line agent across recent guidelines due to its favorable resistance profile and minimal collateral damage 1, 5, 6, 7, 8.